Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gelcaps (Gelcaps Exportadora de México) is a specialized pharmaceutical manufacturing company based in Mexico, recognized for its expertise in softgel capsule technology and complex oral delivery systems. Founded in 1971, the company has operated under various global owners including Patheon and Perrigo, and it is currently a key subsidiary of the Procaps Group following its 2022 acquisition from Advent International as part of Grupo Somar. Gelcaps develops, manufactures, and markets a broad portfolio of branded generic and over-the-counter (OTC) products across therapeutic areas such as urology, pain management, and dermatology. With FDA-approved facilities, the company serves as a strategic CDMO partner for both the Mexican domestic market and international clients, particularly in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gelcaps.